A notable recent study in acute myeloid leukaemia (AML) reported that high-dose VitC activated TET enzymes synergistically with inhibition of mutant isocitrate dehydrogenase 1 (IDH1), resulting in diminished cell growth and increased myeloid differentiation [24]. Here, IDH1 is linked to acute myeloid leukemia.